General assembly

B. Velkeniers (VUB), President

Communications by young investigators    (sponsored by Pfizer)

Chair: P. Petrossians  (ULiège)

Part 1: Translational and clinical studies

• Intestinal delivery of proinsulin and IL-10 via Lactococcus latis combined with low-dose antiCD3 induces antigen-specific FoxP3+ Tregs in autoimmune diabetic mice.
  Pieter-Jan Martens (KUL)
• YIPF5 mutations cause diabetes and microcephaly through disrupted endoplasmic reticulum-to-Golgi trafficking.
  Maria Lytrivi (ULB)
• Sexual symptoms predict all-cause mortality independently of sex steroids in ageing men.
  Leen Antonio (KUL)
• Soft drink intake on time of hypoglycaemia during insulin tolerance test: effects on pituitary response and comfort for the patient.
  Coralie Thiry (ULB)
• Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial.
  Anass El Malahi (UAntwerp)

Part 2: Clinical case reports

• An unusual cause of unilateral adrenal incidentaloma.
  Younes Azzagnuni (ULB)
• A case of a heterozygous inactivating CASR variant with adult-onset symptomatic hypercalcemia requiring extensive surgery.
  Laurens Veldeman (UGhent)

Selected Belgian Publication Award          (sponsored by Sandoz)

Introduced by B. Velkeniers (VUB), President

Clara Depommier et al. Nature Medicine 2019 (25): 1096–1103.
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Presenting author: Clara Depommier (UCL)

Belgian Endocrine Society Lecture Award     (sponsored by Novo)

Introduced by B. Velkeniers (VUB), President

Advanced therapies that improve glucose control and quality of life of people with type 1 diabetes.
Award winner: Pieter Gillard (KUL) 

Farewell